Observational Cohort Study of Dysferlinopathy in China

NCT07035145 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2025-06-24

No results posted yet for this study

Summary

The cohort data to be collected aims to evaluate the phenotype, disease progression, natural history, as well as molecular, genetic, and morphological characteristics of dysferlinopathies (LGMD2B/Miyoshi) in China, contributing to the development of clinical outcome measures and the identification of potential biomarkers for future clinical trials.

Conditions

  • Dysferlinopathy

Sponsors & Collaborators

  • Peking University First Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2025-03-15
Completion
2025-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07035145 on ClinicalTrials.gov